B-Fec Eye Drops are formulated with Bromfenac Sodium 0.09% w/v, a topical NSAID designed to deliver rapid and effective relief from ocular inflammation and pain following cataract surgery. By inhibiting cyclooxygenase activity and reducing the production of prostaglandin E2 (PGE2), B-Fec helps control the inflammatory cascade at the source, supporting faster, more comfortable postoperative recovery.
Key Benefits
- Delivers a strong anti-inflammatory and analgesic effect for postoperative eye care
- Prevents postoperative inflammation by inhibiting PGE2 production
- Reduces surgery-induced pupil constriction and helps maintain intraoperative pupil dilation
- Inhibits the anterior chamber inflammatory response, easing discomfort and pain
- Clinically shown to be superior to ketorolac in reducing postoperative pain
- Supports rapid resolution of ocular pain and inflammation after cataract surgery
Indication
For the treatment of postoperative inflammation and reduction of ocular pain in patients undergoing cataract surgery.
As a trusted Bromfenac Sodium Eye Drops manufacturer in India, I Smith formulates B-Fec to meet stringent quality and efficacy standards for ophthalmic surgical care, giving healthcare partners a dependable option for postoperative inflammation management.
For use by registered medical practitioners only. Not available for direct consumer/online purchase.
